These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 11790655

  • 1. Airway hyperresponsiveness in transgenic mice overexpressing platelet activating factor receptor is mediated by an atropine-sensitive pathway.
    Nagase T, Ishii S, Shindou H, Ouchi Y, Shimizu T.
    Am J Respir Crit Care Med; 2002 Jan 15; 165(2):200-5. PubMed ID: 11790655
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Platelet activating factor-induced neuronal apoptosis is initiated independently of its G-protein coupled PAF receptor and is inhibited by the benzoate orsellinic acid.
    Ryan SD, Harris CS, Mo F, Lee H, Hou ST, Bazan NG, Haddad PS, Arnason JT, Bennett SA.
    J Neurochem; 2007 Oct 15; 103(1):88-97. PubMed ID: 17877634
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice.
    Nagase T, Ishii S, Kume K, Uozumi N, Izumi T, Ouchi Y, Shimizu T.
    J Clin Invest; 1999 Oct 15; 104(8):1071-6. PubMed ID: 10525045
    [Abstract] [Full Text] [Related]

  • 10. Platelet-activating factor receptor develops airway hyperresponsiveness independently of airway inflammation in a murine asthma model.
    Ishii S, Nagase T, Shindou H, Takizawa H, Ouchi Y, Shimizu T.
    J Immunol; 2004 Jun 01; 172(11):7095-102. PubMed ID: 15153532
    [Abstract] [Full Text] [Related]

  • 11. Regulation of airway muscarinic cholinergic receptor subtypes by chronic anticholinergic treatment.
    Witt-Enderby PA, Yamamura HI, Halonen M, Lai J, Palmer JD, Bloom JW.
    Mol Pharmacol; 1995 Mar 01; 47(3):485-90. PubMed ID: 7700247
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. SIRT1 attenuates PAF-induced MMP-2 production via down-regulation of PAF receptor expression in vascular smooth muscle cells.
    Kim YH, Bae JU, Lee SJ, Park SY, Kim CD.
    Vascul Pharmacol; 2015 Sep 01; 72():35-42. PubMed ID: 25967595
    [Abstract] [Full Text] [Related]

  • 14. Janus kinase 2 activation by the platelet-activating factor receptor (PAFR): roles of Tyk2 and PAFR C terminus.
    Lukashova V, Chen Z, Duhé RJ, Rola-Pleszczynski M, Stanková J.
    J Immunol; 2003 Oct 01; 171(7):3794-800. PubMed ID: 14500680
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF).
    Ferreira MA, Barcelos LS, Teixeira MM, Bakhle YS, Andrade SP.
    Life Sci; 2007 Jun 27; 81(3):210-7. PubMed ID: 17588613
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Susceptibility to platelet-activating factor-induced airway hyperreactivity and hyperpermeability: interstrain variation and genetic control.
    Longphre M, Kleeberger SR.
    Am J Respir Cell Mol Biol; 1995 Nov 27; 13(5):586-94. PubMed ID: 7576695
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of platelet-activating factor responsiveness during maturation of human dendritic cells.
    Dichmann S, Rheinen H, Panther E, Herouy Y, Czech W, Termeer C, Simon JC, Gebicke-Haerter PJ, Norgauer J.
    J Cell Physiol; 2000 Dec 27; 185(3):394-400. PubMed ID: 11056009
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.